The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

The federal government scrapped a plan to have health insurance companies fund coverage of obesity drugs for seniors, opting instead to pay for the medicine with taxpayer dollars through the ...

Medicare has delayed its BALANCE program for weight-loss drugs like Wegovy. Discover the new 'bridge program' that will offer ...

CMS Deputy Administrator and Director of Medicare Chris Klomp and Deputy Administrator and Chief of Staff Stephanie Carlton talked with AHA Board Chair Marc Boom, M.D., president and CEO, Houston ...

A representative from the Centers for Medicare & Medicaid Services was scheduled to dial in to a recent meeting of state regulators to hear concerns about Medicare administration. But CMS never joined ...

CMS will expand its Medicare Advantage Value-Based Insurance Design Model to include 25 states in 2019. Here are four things to know about the initiative. 1. The five-year model allows Medicare ...

Yesterday, US health insurance stocks took an almighty beating, as news broke that the Centers for Medicaid and Medicare Services ("CMS") had announced a proposed rate increase for Medicare Advantage ...

CMS is requesting information about how to best help health insurers sell policies across state lines, the agency said March 6. 1. CMS is seeking advice on how to eliminate regulatory, operational and ...

Agent associations are speaking out against a new federal policy that they say is hindering agents from enrolling people in coverage on the federal health insurance marketplace. On Aug. 29, the ...

The Trump administration announced a 2.48% payment increase for Medicare Advantage plans for 2027, a much bigger boost than an earlier proposal that kept rates flat.